Really small vascular disease of the brain

Neurology

Volumn 78, Issue 2, 2012, Pages 82-83

  Nyquist, Paul A ^a   Barzilay, Joshua I ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN FUNCTION; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; ATHEROSCLEROSIS; BRAIN; CLASSIFICATION; FEMALE; LACUNAR STROKE; MALE; NOTE; PATHOLOGY;

ATHEROSCLEROSIS; BRAIN; FEMALE; HUMANS; MALE; STROKE, LACUNAR;

EID: 84857387198     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182447e7c     Document Type: Editorial

References (10)

1. Bryan RN, Cai J, Burke G, et al. Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: The Atherosclerosis Risk in Communities Study. AJNR Am J Neuroradiol 1999;20:1273-1280.
2. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 1998;55:1217-1225.
3. Longstreth WT Jr, Dulberg C, Manolio TA, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2002;33:2376-2382.
4. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM; Rotterdam Scan Study. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2003;34:392-396.
5. Bezerra DC, Sharrett AR, Matsushita K, et al. Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study. Neurology 2012;78:102-108.
6. Lesage SR, Mosley TH, Wong TY, et al. Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology 2009;73:862-868.
7. Barzilay J, Go P, O'Donnell M, et al; ONTARGET and TRANSCEND Investigators. Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Arch Intern Med 2011;171:142-150.
8. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005;48:2460-2469.
9. Pergola PE, Raskin P, Toto RD, et al; BEAM Study Investigators. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 2011;365:327-336.
10. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature; implications for end-organ damage. J Appl Physiol 2008;105:1652-1660.